All Stories

  1. Why diabetes matters in dementia studies. Excluding diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimers disease
  2. Accurate quantification of canine mitochondrial DNA copy number and its evaluation as a biomarker of brain injury
  3. Tackling overweight and obesity in the youth with the PAS GRAS project
  4. Co-regulation and synteny of GFM2 and NSA2 links ribosomal function in mitochondria and the cytosol with chronic kidney disease
  5. Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker
  6. Stress‐dependent macromolecular crowding in the mitochondrial matrix
  7. Viscosity and macromolecular crowding in the mitochondrial matrix: Impact on protein diffusion and structure
  8. Preclinical evidence for mitochondrial DNA as a potential blood biomarker for chemotherapy-induced peripheral neuropathy
  9. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
  10. Accurate Measurement of Cellular and Cell-Free Circulating Mitochondrial DNA Content from Human Blood Samples Using Real-Time Quantitative PCR
  11. Supplementation with a prebiotic (polydextrose) in obese mouse pregnancy improves maternal glucose homeostasis and protects against offspring obesity
  12. A case for measuring both cellular and cell‐free mitochondrial DNA as a disease biomarker in human blood
  13. Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer
  14. Effects of thyroid hormone on mitochondria and metabolism of human preimplantation embryos
  15. The Detection and Partial Localisation of Heteroplasmic Mutations in the Mitochondrial Genome of Patients with Diabetic Retinopathy
  16. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease
  17. Regional mitochondrial DNA and cell-type changes in post-mortem brains of non-diabetic Alzheimer’s disease are not present in diabetic Alzheimer’s disease
  18. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis
  19. Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits
  20. Mitochondrial DNA as a Potential Translational Biomarker of Mitochondrial Dysfunction in Drug-Induced Toxicity Studies
  21. Potential Mechanisms of Mitochondrial DNA Mediated Acquired Mitochondrial Disease
  22. Mitochondrial genes are altered in blood early in Alzheimer's disease
  23. Hyperglycemia induced damage to mitochondrial respiration in renal mesangial and tubular cells: Implications for diabetic nephropathy
  24. Accurate quantification of mouse mitochondrial DNA without co-amplification of nuclear mitochondrial insertion sequences
  25. Altered circulating mitochondrial DNA and increased inflammation in patients with diabetic retinopathy
  26. Equilibrative nucleoside transporter 3 depletion in β-cells impairs mitochondrial function and promotes apoptosis: Relationship to pigmented hypertrichotic dermatosis with insulin-dependent diabetes
  27. Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy
  28. Understanding the Implications of Mitochondrial DNA Variation in the Health of Black Southern African Populations: The 2014 Workshop
  29. Accurate Measurement of Circulating Mitochondrial DNA Content from Human Blood Samples Using Real-Time Quantitative PCR
  30. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?
  31. Nop-7-associated 2 (NSA2), a candidate gene for diabetic nephropathy, is involved in the TGFβ1 pathway
  32. 10 Mitochondrial dysfunction in diabetic nephropathy
  33. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy
  34. Mitochondrial DNA as a non-invasive biomarker: Accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution bias
  35. Hyperglycemia induces elevated expression of thyroid hormone binding protein in vivo in kidney and heart and in vitro in mesangial cells
  36. Increased peripheral blood mitochondrial DNA in type 2 diabetic patients with nephropathy
  37. Glucose regulation of CDK7, a putative thiol related gene, in experimental diabetic nephropathy
  38. Glucose regulation of β-defensin-1 mRNA in human renal cells
  39. Scaphoid views: a need for standardisation
  40. Elevated levels of beta defensin-1 mRNA in diabetic kidneys of GK rats
  41. Isolation of Diabetes-Associated Kidney Genes Using Differential Display
  42. Molecular characterisation of theXenopus laevis chaperonin geneCctg
  43. Drosophila melanogaster P1 genomic clone DS05563 contains the chaperonin-encoding gene Cctg
  44. Cloning, structure and mRNA expression of human Cctg, which encodes the chaperonin subunit CCTγ
  45. Identification of differentially expressed genes during the progression of diabetic nephropathy
  46. THE GENE ENCODING HUMAN RIBOSOMAL PROTEIN L27 IS DEVELOPMENTALLY REGULATED IN HUMAN KIDNEY
  47. The Tcp-1-related gene, Cctg, maps to mouse Chromosome 3
  48. Cloning and nucleotide sequence of a full length cDNA encoding ribosomal protein L27 from human fetal kidney
  49. Parathyroid hormone related peptide gene expression in human fetal and adult heart
  50. Parathyroid hormone-related peptide: Expression in fetal and neonatal development
  51. A discordance between the human muscle NCAM sequence and those seen in other NCAM cDNA clones
  52. Molecular genetics of Pseudomonas syringae pathovar pisi: plasmid involvement in cultivar-specific incompatibility
  53. Parathyroid hormone-related peptide in normal human fetal development
  54. Molecular cloning of a human thyrotropin receptor cDNA fragment
  55. A simple high yield method for the preparation of lambda gt10 DNA suitable for subcloning, amplification and direct sequencing